| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.02 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.02 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.02 |